Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Cormedix Inc (CRMD)
Cormedix Inc (CRMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 179,783
  • Shares Outstanding, K 54,812
  • Annual Sales, $ 70 K
  • Annual Income, $ -29,700 K
  • 60-Month Beta 1.79
  • Price/Sales 5,190.75
  • Price/Cash Flow N/A
  • Price/Book 2.14
Trade CRMD with:

Options Overview Details

View History
  • Implied Volatility 74.89% ( +2.62%)
  • Historical Volatility 46.40%
  • IV Percentile 35%
  • IV Rank 16.77%
  • IV High 254.51% on 11/14/23
  • IV Low 38.69% on 01/10/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 239
  • Volume Avg (30-Day) 443
  • Put/Call OI Ratio 0.57
  • Today's Open Interest 14,598
  • Open Int (30-Day) 12,871

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate -0.21
  • Number of Estimates 1
  • High Estimate -0.21
  • Low Estimate -0.21
  • Prior Year -0.20
  • Growth Rate Est. (year over year) -5.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.89 +13.49%
on 02/08/24
3.39 -3.24%
on 01/30/24
unch (unch)
since 01/23/24
3-Month
2.89 +13.49%
on 02/08/24
4.03 -18.51%
on 12/27/23
-0.38 (-10.38%)
since 11/22/23
52-Week
2.57 +27.63%
on 11/15/23
6.09 -46.14%
on 06/22/23
-0.73 (-18.20%)
since 02/23/23

Most Recent Stories

More News
CorMedix (CRMD) Q3 2023 Earnings Call Transcript

CRMD earnings call for the period ending September 30, 2023.

CRMD : 3.28 (+1.23%)
CorMedix: Q3 Earnings Snapshot

CorMedix: Q3 Earnings Snapshot

CRMD : 3.28 (+1.23%)
CorMedix (CRMD) Q2 2023 Earnings Call Transcript

CRMD earnings call for the period ending June 30, 2023.

CRMD : 3.28 (+1.23%)
CorMedix: Q2 Earnings Snapshot

CorMedix: Q2 Earnings Snapshot

CRMD : 3.28 (+1.23%)
Why Shares of CorMedix Are Slumping Thursday

The company announced a stock sale and the sale of prefunded warrants.

CRMD : 3.28 (+1.23%)
Stocks Climb Before the Open as Investors Await Key U.S. GDP Data, Nike Earnings on Tap

September S&P 500 futures (ESU23) are up +0.24%, and September Nasdaq 100 E-Mini futures (NQU23) are up +0.27% this morning after three major U.S. benchmark indices ended the regular session mixed as investors...

ESU23 : 4,491.72s (-0.32%)
NQU23 : 15,435.20s (-0.28%)
CCL : 15.23 (+0.13%)
NCLH : 16.17 (-1.04%)
NFLX : 583.56 (-0.83%)
NVDA : 788.17 (+0.36%)
GIS : 65.32 (+0.38%)
NKE : 105.63 (+0.52%)
RNO.P.DX : 37.545 (-0.66%)
HMB.S.DX : 141.220 (+0.89%)
MU : 86.00 (+0.10%)
WFC : 53.86 (+0.92%)
3 Biotech Stocks Losing Market Value

There is a growing demand for healthcare solutions, and the biotech industry will likely benefit from it. However, not all biotech stocks are well-positioned to capitalize on the industry tailwinds. Therefore,...

BCYC : 24.64 (+2.75%)
CRMD : 3.28 (+1.23%)
XXII : 0.1390 (-7.33%)
CorMedix (CRMD) Q1 2023 Earnings Call Transcript

CRMD earnings call for the period ending March 31, 2023.

CRMD : 3.28 (+1.23%)
CorMedix: Q1 Earnings Snapshot

CorMedix: Q1 Earnings Snapshot

CRMD : 3.28 (+1.23%)
How Much Upside is Left in CorMedix (CRMD)? Wall Street Analysts Think 198.21%

The average of price targets set by Wall Street analysts indicates a potential upside of 198.2% in CorMedix (CRMD). While the effectiveness of this highly sought-after metric is questionable, the positive...

CRMD : 3.28 (+1.23%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

CorMedix Inc. is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company is focused on developing its lead product Defencath (TM), a novel, antibacterial and antifungal solution designed...

See More

Key Turning Points

3rd Resistance Point 3.41
2nd Resistance Point 3.35
1st Resistance Point 3.32
Last Price 3.28
1st Support Level 3.22
2nd Support Level 3.16
3rd Support Level 3.13

See More

52-Week High 6.09
Fibonacci 61.8% 4.75
Fibonacci 50% 4.33
Fibonacci 38.2% 3.91
Last Price 3.28
52-Week Low 2.57

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar